Because periodontal ligament (PDL) cells are reported to contain progenitor or stem cell populations, they are considered a beneficial cell source for clinical periodontal regeneration. Both bone morphogenetic protein 4 (BMP4) and human telomerase reverse transcriptase (hTERT) have essential roles in the modulation of stem cell properties. In this study we report for the first time that the combined ectopic expression of BMP4 and hTERT significantly enhanced the multipotent differentiation efficiency and capacity of human PDL fibroblasts (PFs), as shown by osteogenic, adipogenic and neurogenic differentiation in vitro, and cementum/PDL-like tissue regeneration in vivo. These findings may be attributed, at least in part, to the original upregulation of important stem cell markers, such as scleraxis, Stro-1 and CD146, and the extremely lowered threshold for BMP concentration to activate BMP signaling by enhanced basal phosphorylation levels of Smad 1/5/8. In addition, the significantly reduced expression levels of CD146 and CD90 with the presence of Noggin confirms the direct effect of BMP4 on the stem cell-like phenotype of genetically modified PF cells (BT-PFs). Furthermore, BT-PFs exhibited a high neural differentiation capacity (475%). After transplantation into NOD/SCID mice, genetically modified-PFs generated cementum/PDL-like structures on the surface of the carrier. The multipotency of these modified cells potentially provides an attractive source of stem cells for therapeutic purposes and regenerative medicine.
INTRODUCTION
The periodontal ligament (PDL) is a nonmineralized connective tissue embedded between the roots of teeth and the inner wall of the alveolar socket bone, providing anchorage of teeth within the jaw and cushioning for the mechanical stresses of mastication. 1,2 In particular, a number of studies have shown that there is a novel population of multipotent postnatal stem cells in PDL that is partially similar to other mesenchymal stem cells (MSCs) with respect to their capacity to develop into osteoblasts/cementoblasts, adipocytes and neuron-like cells in vitro, [3] [4] [5] as well as to uniquely form cementum/PDL-like tissue in vivo. [6] [7] [8] Therefore, PDL cells should be greatly beneficial for clinical periodontal regeneration. However, primary fibroblast-like cells acquired from the PDL are heterogeneous populations with different self-renewal and differentiation potentials. A long-term culture of PDL fibroblasts can diminish the number of cells, resulting in a loss of their primary phenotype. 9 In particular, previous reports have demonstrated that the efficiency of differentiation into osteogenic and neurogenic lineages in vitro was seriously limited and varied between the cell lines derived from the PDL. [10] [11] [12] Most importantly, a critical requirement in stem cell-associated experiments and their application in tissue regeneration is the availability of a stem cell-enriched population that retains the features of its original constituent cells. 3 Several studies have demonstrated that the ectopic expression of human telomerase reverse transcriptase (hTERT) alone or in combination with defined genes enables MSCs to escape senescence and significantly increases the lifespan of MSCs during ex vivo expansion. In addition, hTERT-expressing MSCs exhibit an enhanced capacity for bone formation in vitro and in vivo. [13] [14] [15] Collectively, hTERT prevents MSCs from terminal differentiation and preserves a higher ratio of osteogenic precursor cells with enhanced growth and functional abilities. 16 Several signaling pathways have been demonstrated to have a role in stem cell determination. These pathways include those of leukemia inhibitory factor, Wnt protein and bone morphogenetic proteins (BMPs). 17 Among these, BMPs are members of the distinct transforming growth factor-b family related to secreted ligands. They are characterized by their bone-forming performance and have essential roles in many biological processes, including cellular proliferation, differentiation and skeletal and nervous development. [18] [19] [20] [21] Base on these considerations, we hypothesized that both BMP4 and hTERT expressions may enhance the differentiation potential of PDL fibroblasts, thus providing the establishment of a stem cell-enriched cell line from primary PDL fibroblasts (PFs) for applications in cell therapy and tissue regeneration.
In this study, our results demonstrate for the first time that the ectopic expressions of BMP4 and hTERT in genetically modified PDL fibroblasts (BT-PFs) indeed enhanced the expressions of several MSC markers, indicating that the proportion of the stem cell population in BT-PFs was enlarged. Moreover, the BT-PF cell line also exhibited a high efficiency to undergo differentiation along multiple lineages, including osteogenic, adipogenic and neurogenic in vitro. The in vivo assay revealed the successful ability of BT-PFs to generate PDL-like structures in nude mice for potential periodontal regeneration applications.
RESULTS

Ectopic expressions of BMP4 and hTERT in transfected PFs
Fibroblasts obtained from the fragments of PDLs displayed outgrowth in explant cultures. At the third passage, cells were co-transfected with BMP4 and hTERT expression vectors. We first investigated the mRNA expressions of exogenous BMP4 and hTERT in PFs and BT-PFs by semiquantitative reverse transcriptase PCR (RT-PCR) using specific primers ( Figure 1a ). Both transgene-derived BMP4 and hTERT were detected in BT-PFs but not in PFs. Although the expression of endogenous BMP4 was also observed in PFs, the level of BMP4 secreted by BT-PFs was significantly higher than that secreted by PFs (Po0.001; Figure 1b) . Consistent results were observed in the telomerase activity assay; no endogenous hTERT expression was found in either PFs or BT-PFs compared with HEK 293 cells (positive control), whereas a remarkable difference of telomerase activity was noted between PFs and BT-PFs (Po0.001; Figure 1c ). Next, we assessed the expression levels of PDL phenotype-related genes, such as type I collagen (Col I), periostin (POSTN) and scleraxis, in PFs and BT-PFs by semiquantitative RT-PCR (Figure 1d ). The results revealed that Col I and POSTN were expressed in PFs and BT-PFs, but a clear expression of scleraxis, a tendon-specific marker expressed in PDL stem cells (PDLSCs), 3 was only detected in BT-PFs. Furthermore, very few expressions of these genes were found in Saos-2 cells, suggesting that ectopic expressions of BMP4 and hTERT in transfected PFs might have transformed PDL mature fibroblasts into PDL progenitor cells or stem cells.
Surface marker characterization of PFs and BT-PFs using flow cytometry and effect of BMP4 on the kinetics of expression of surface markers To characterize BT-PFs by surface markers and compare any variations with parental PFs, we employed a panel of cell-surface markers previously used to define the phenotype of MSCs, 7, 22, 23 including markers related to MSC multipotency (Stro-1, CD90, CD133 and CD146) and cell adhesion/matrix receptors (CD29). Flow cytometric analyses showed that BT-PFs had significantly higher expression levels of all the cell-surface markers under regular medium (CM) conditions (Po0.05; Figure 2 ), implying that BT-PFs contained a higher proportion of progenitor cells or stem cells. To evaluate the BMP4 effect on the stem cell-like phenotype, PFs and BT-PFs were cultivated with Noggin (an antagonist of BMP4) for 3 days and then flow cytometric analyses were performed. The results showed that Noggin treatment significantly decreased the expression levels of CD146 and CD90 in BT-PFs, whereas the expression levels of CD29 were significantly increased (Po0.05) after adding Noggin to the culture of BT-PFs. In addition, the significant difference of Stro-1 and CD133 expression was not observed in BT-PFs between CM conditions and Noggin treatment. Furthermore, no significant change in the expression of all the cell-surface markers was found in PFs after antagonism of BMP4 signaling by Noggin treatment. These data indicated that the upregulation of CD146 and CD90 may be attributed, at least in part, to the overexpression of BMP4, and ectopic expression of hTERT may exhibit the dominant effect on the upregulation of Stro-1, CD29 and CD133 in PFs, especially for CD29 because of the higher expression after Noggin treatment of BT-PFs.
In vitro differentiation assay of PFs and BT-PFs
To investigate the BT-PF potential of undergoing multiple-lineage differentiation compared with primary PFs, the established BT-PFs and PFs were supplemented with various induction media, including osteogenic differentiation medium (oDM) and adipogenic differentiation medium (aDM).
The results demonstrate that the osteogenic differentiation of BT-PFs resulted in positive staining for alkaline phosphatase after 7 days of culture ( Figure 3b ) and for alizarin red staining, showing a lot of mineralized nodule production after 28 days of culture (Figure 3d) . However, the strongly positive staining results were not observed and only limited amounts of mineralized nodule formation were found in PFs (Figures 3a and c) . Upon examination of osteogenic differentiation markers, the results showed that in BT-PFs, expressions of the genes encoding bone matrix proteins, alkaline phosphatase (ALP) and bone sialoprotein (BSP), were strikingly elevated in oDM at 7 days (Figure 3g ). In the adipogenic differentiation assay, after 5 days of culture with aDM, numerous oil red O-positive lipid vesicles were observed in BT-PFs (Figure 3f, arrow) . This development was related to the upregulated mRNA expressions of two adipocyte-specific genes, lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor g2 (PPARg2), as detected by RT-PCR (Figure 3h ). These results were not observed in PFs treated with aDM (Figures 3e and h ). Taken together, these data indicate that BT-PFs demonstrate efficient differentiation into osteogenic and adipogenic lineages when cultured in differentiation medium when compared with PFs.
Analysis of Smad signaling pathways during osteogenic induction of PFs and BT-PFs
To evaluate the role of BMP4 in the process of osteogenic differentiation of BT-PFs, we first performed a mineralization assay with PFs and BT-PFs cultured for 28 days in the presence or absence of recombinant human BMP (rhBMP4; 250 ng ml -1 ). The level of total BMP4 in the oDM was evaluated on the second day after adding rhBMP4. As identified by alizarin red staining (Figure 4a ), PFs formed moderate mineralized nodules in oDM with rhBMP4. In contrast, PFs produced few mineralized nodules in oDM without rhBMP4. However, extensive mineralized nodules were detected in BT-PFs cultured with oDM lacking rhBMP4. Next, to see intracellular signaling events in response to BMP4, we stimulated PFs and BT-PFs with or without rhBMP4 (250 ng ml -1 ) in oDM and checked the phosphorylation of Smad 1/5/8, a major pathway recognized to be activated by BMP. The results of the western blot assay showed that under CM conditions, Figure 2 Effect of BMP4 on the kinetic change of surface marker expression. Cells were incubated in regular medium with or without the supplement of Noggin (150 ng ml -1 ) for 3 days and the surface marker expression analyzed by flow cytometry. Flow cytometric analyses revealed that BT-PFs had significantly higher expression levels of all the cell-surface markers under regular medium conditions (*Po0.05). Inhibition of BMP4 by Noggin significantly decreased the expression levels of CD146 and CD90 in BT-PFs, whereas the expression levels of CD29 were significantly increased (*Po0.05).
the basal phosphorylation level of Smad 1/5/8 in BT-PF cells was higher than that in PFs (Figure 4b ). Additionally, the activation of Smad 1/5/8 was not detectable in PFs cultured with oDM alone; however, rhBMP4 treatment induced a transient Smad 1/5/8 phosphorylation, which peaked at 60 min in PFs cultured with oDM. Comparatively, the amounts of phosphorylated Smad 1/5/8 in BT-PFs increased by a 30-min treatment with oDM alone and remained elevated for at least 90 min (Figure 4c ). This finding implies that the threshold for the BMP concentration to activate the BMP signal in oDM alone might be markedly reduced (from ng ml -1 to pg ml -1 ) by the initially enhanced basal phosphorylation level of Smad 1/5/8 in CM as a consequence of the enforced expression of BMP4. Moreover, the sustained activation of the BMP signal in oDM (at least 90 min) may have contributed to a regulatory mechanism for the promoted osteogenic differentiation potential of BT-PFs.
Morphological transformation and marker analysis of PFs and BT-PFs during neural induction
The noticeable characteristics of MSC neural differentiation include a rapid response of dramatic morphological changes under neural induction. 24, 25 Accordingly, we investigated the efficiency of neural differentiation of PFs and BT-PFs in response to neuronal differentiation medium (nDM) at a morphological level monitored by timelapse video microscopy ( Figure 5a ). Initially, both PFs and BT-PFs exhibited fibroblast morphologies. When PFs and BT-PFs were exposed to nDM, the majority of BT-PFs underwent expected changes in morphology and then started to demonstrate neuron-like morphological transformations (Figure 5a , black arrow and white arrowhead) within a few hours. Interestingly, a representative responsive BT-PF ( Figure 5a , black arrow) at 08 h 10¢ underwent division, yielding a doublet through cytokinesis. By 12 h 50¢, the mitotic cells separated while continuing to display a neuron-like shape until the end of observation at 24 h 00¢ (Figure 5a , two black arrows). In the same field, cells acquired a neuron-like shape but did not divide during the 24-h observation period (Figure 5a , white arrowhead). Very few responsive PFs exhibiting neuronal morphologies (Figure 5a , red arrow) were observed after 10 h 00¢ of nDM treatment.
Additionally, double-label immunocytofluorescence indicated that BT-PFs differentiated along the neurogenic linage in terms of the expressions of nestin (Figure 5c ), glial fibrillary acidic protein (GFAP; Figure 5e ) and microtubule-associated protein 2 (MAP; Figure 5g ). Semiquantitative RT-PCR analysis also showed an upregulation in the expression of lineage-specific marker genes (Figure 5h ). We did not obtain these results for PFs treated with nDM (Figures 5b, d, f and h ).
In summary, video time-lapse microscopy demonstrated that BT-PFs exhibited expected results in response to physiological inducers under neural induction at the morphological level (see video in Supplementary Videos 1 and 2). Most notably, as identified by marker expressions, the capacity to differentiate into neuron-like cells greatly increased in BT-PFs when compared with primary PFs.
In vivo differentiation of PFs and BT-PFs
To assess the tissue-regenerative ability of BT-PFs in vivo, PFs and BT-PFs were transplanted into nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice. Typical cementum/PDL-like structures was generated on the surface of the hydroxyapatite/tricalcium phosphate (HA/TCP) carrier by BT-PFs. Hematoxylin and eosin and trichrome staining revealed collagen fibers inserting perpendicularly into the cementum/bone-like tissue, imitating the physiological nature of Sharpey's fibers in the PDL (Figures 6c and f) . In contrast, no cementum/PDL-like structures were observed at the border of the HA/TCP with PFs (Figures 6b and e) or controls without cell transplants (Figures 6a and d) . Moreover, human BT-PFs contributed to the formation of collagen fibers within the transplants, as exhibited by the strong reactivity of the cementum/PDL-like structures with human-specific anti-Col I antibody ( Figure 6i 
DISCUSSION
The utilization of PDLSCs for PDL engineering has greatly contributed to the progress of periodontal regenerative therapies. 8 However, the application of autologous stem cell populations may be restricted because of patient variation in age, disease condition and tissue quality. It is frequently difficult to provide enough cells from one donor for the purpose of tissue engineering, because the proliferation and differentiation potentials in PDLSCs are variable between donors. 26, 27 Additionally, the osteogenic differentiation of PDLSCs has been assessed previously, and the data show that PDLSCs generate scarce calcified nodules compared with the other types of stem cells derived from bone marrow and pulp tissue. 3 To overcome these problems, we attempted to extend the lifespan of PFs and to explore whether PFs genetically modified with hTERT and BMP4 enhance their differentiation capability. Several researchers have demonstrated that immortalized human PFs can be established by introducing hTERT and coexpression of hTERT with HPV16 or SV40 oncogenes. 10, 28 However, these cell lines displayed limited differentiation potentials or failed to retain the characteristics of the parental cells. On the other hand, recent studies have also shown that the multipotent PF cell line can be obtained from ectopically hTERT-and SV40-expressing PFs while maintaining the phenotype of primary PFs. 6, 11 However, using gene transfer for these oncogenes in PFs is a serious obstacle to the eventual use of the transfected cells for therapeutic applications. Our results agree with those of others who have found that the introduction of hTERT alone is insufficient for extending the lifespan of primary PFs. 9, 15 In addition, we failed to establish a stably transfected PF cell line using a single gene transfer with BMP4 in our system. To our knowledge, this is the first study in which both exogenous BMP4 and hTERT were successfully introduced into PFs using a gene transfection technique, resulting in a stable BMP4-and hTERT-expressing PF cell line after G418 selection. It was reported that human fibroblasts can be transformed into embryonic stem cell-like cell lines by ectopic expression of four transcription factors: OCT4, SOX2, c-MYC and KLF4. 29 In this study, we found that PF cells transfected with BMP4 and hTERT yielded significantly higher levels of BMP4 protein and expressed relatively stronger telomerase activity. Moreover, the upregulation of the important stem cell markers, such as scleraxis, Stro-1, CD146, CD29, CD90 and CD133, in BT-PF cells suggested that PDL mature fibroblasts were transformed into PDL progenitor cells or stem cells with enhanced multipotency. Therefore, the strategy used for gene transfer in this study may be helpful to find the combination of potential reprogramming genes to generate the induced pluripotent stem cells from PFs without the transfer of potentially harmful genes.
Similar to our results, previous studies have reported that the kinetic change of some surface marker expression after hTERT gene transfer was observed. However, the kinetic expression of individual markers, such as Stro-1 and CD29, in hTERT-transduced cells is variable between the different cell lines. [30] [31] [32] [33] In addition, the upregulated expression level of the endothelial markers in embryoid bodies by a boost of BMP4 was noted. 34 We found that the significantly reduced expression levels of CD146 and CD90 in BT-PFs with the presence of Noggin confirms the direct effect of BMP4, at least in part, on the stem cell-like phenotype of BT-PFs. Furthermore, we noted that the expression level of Stro-1 was not upregulated in BMP4-transduced PF cells (data not shown). Taken together, these results suggest that the combined expression of BMP4 and hTERT may have crucial roles in the regulation of stem cell marker expressions in BT-PFs.
In this study, we found that BT-PFs responded more efficiently to the induction mediums in vitro compared with PFs. Similar to at 00 h 00¢ and ended at 24 h 00¢. A similar fibroblast-like PF (red and green arrow) and BT-PF (black, white arrow and white arrowhead) at 00 h 00¢ were identified before differentiation. Retraction of the cell body and process elaboration was evident with increasing time at around 03 h 00¢ in the induced BT-PF (black arrow and white arrowhead), compared with the PF induced in nDM. After 08 h 10¢ of nDM treatment, a differentiating BT-PF exhibiting a neuronal morphology (black arrow) underwent division, yielding a doublet through cytokinesis (two black arrows) at 09 h 40¢. The mitotic cells separated while continuing to display a neuron-like shape until the end of observation at 24 h 00¢ (two black arrows). In the same field, cells had a neuron-like shape but did not divide during this 24 h period of observation (white arrowhead), and an unresponsive, flat BT-PF was also noticed during the 24 h observation period (white arrow). A minimally responsive PF exhibiting a neuronal morphology (red arrow) was observed after 10 h 00¢ of nDM treatment. In the same field, another fibroblast-like PF (green arrow) underwent cytokinesis and then produced two daughter cells (two green arrows) at 13 h 45¢. Dissimilar to the responsive BT-PF in the mitosis process, the two daughter cells maintained a fibroblast-like morphology until the end of observation at 24 h 00¢ (green arrow). PFs and BT-PFs were cultured for 3 days in nDM and subjected to immunocytochemical staining with antibodies to nestin (red), GFAP (red) and MAP (red). Nuclei were counterstained with 4,6-diamidino-2-phenylindole (DAPI; blue). Emergent cells positive for nestin (c), GFAP (e) and MAP (g) were present in BT-PFs when cultured with nDM. These results were not observed for PFs when cultured with nDM (b, d and f). Semiquantitative RT-PCR revealed the upregulated mRNA expressions of neurogenic markers nestin and GFAP in BT-PFs under neurogenic induction for 3 days, compared with PFs under the same conditions (h).
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previous reports, 35, 36 modulating BT-PFs with ectopic expression of BMP4 extremely enhanced osteogenic differentiation, as shown in alkaline phosphatase and alizarin red staining. The BMPs elicit their biological functions by means of signal transduction via three BMP receptors (BMPR1a, 1b and 2). These receptors then phosphorylate Smad 1/5/8 to execute intracellular signaling and regulate the transcription of BMP-responsive genes. 17 It is interesting to note that the basal level (in CM) of phospho-Smad 1/5/8 in BT-PFs was enhanced by BMP4 transgenes compared with those in PFs, suggesting that upregulating BMP signals in an autocrine pattern might magnify the sensitive and osteogenic response of BT-PFs to the inductive medium. In the further Smad signal analysis, we actually found that Smad 1/5/8 was constitutively phosphorylated (at least 90 min) in BT-PFs by treatment with oDM alone. Similarly, transient activation of Smad 1/5/8 and moderately enhanced osteogenic differentiation were observed in PFs after stimulation with rhBMP4 and oDM. However, the remarkably enhanced osteogenic differentiation of BT-PFs failed to be reproduced even by direct delivery of an excessive concentration (250 ng ml -1 ) of rhBMP4 to stimulate PFs through osteogenic induction. These results suggest that the intrinsic differentiation capacity of BT-PFs have been entirely modified by the synergistic effect of BMP4 and hTERT co-transfection.
Furthermore, it has been reported that only a small population of neural crest-like cells (o10%) from human PDL might show the potential for neurogenic differentiation. 12 Additionally, other studies have reported that neural stem cells with neural potentiality could be obtained only from PDL-derived spheres (or neurospheres) and that several processes of induction protocols were noted. 5, 37 In this study, BT-PFs exhibited a high neural differentiation capacity after exposure to fully defined induction medium in a simple procedure that led to the acquisition of a neuronal morphology and stable expression neurogenic differentiation markers by 475% of the cells. Our findings regarding the morphological conversion of BT-PFs during neural induction agree with a previous study in which neuron-like cells were initiated directly from adult MSCs before, during, after and even without intervening cell division. 25 Consistent with previous studies on neural differentiation of PDL-derived stem cells, 5, 12, 37 we found, at the protein level, positive expression of human nestin, GFAP and Figure 6 In vivo differentiation capacity of PFs and BT-PFs. As a control, HA/TCP was transplanted without cells into NOD/SCID mice. Histological sections were stained with hematoxylin and eosin (H&E; a-c), trichrome (d-f) or treated immunohistochemically (g-o). After 8 weeks of transplantation, BT-PFs were able to form cementum/bone-like structures (arrowheads in c, f) on the surface of HA/TCP (*) and were capable of generating Sharpey's fibers inserted into the cementum bone-like tissues (black arrows). Newly generated cementum/bone-like structures (arrowheads in i and o) were positive for hCol I, hPOSTN and hOPN antibody staining (i, l and o). The inset shows that a pre-immunoserum control was negative for human-specific anti-Col I antibody staining. The scale bar represents 50 mm for (a-o).
MAP, implying neurogenic differentiation. The expressions of nestin and GFAP were verified at the RNA level as well. Therefore, these results suggest that the synergistic expressions of BMP4 and hTERT are effective in neurogenic differentiation and that this strategy could be used as a platform for future studies to explore the synergistic or additive effects of BMP4 and hTERT on neural regeneration.
Typically, cementum/PDL-like structures can be produced after transplantation of PDLSCs into immunocompromised mice. 38, 39 Moreover, it has been reported that the virally transduced MSCs expressing BMP4 or BMP2 can promote more complete bone healing or periodontal regeneration in vivo. 40, 41 Our results showed that a cementum/PDL-like complex was observed only in BT-PF transplants in which collagen fibers had connected the newly formed cementumlike tissues that mimicked physiological attachments of Sharpey's fibers. To distinguish whether the exogenous cells or host cells were responsible for the formation of the cementum/PDL-like structures, we investigated the expressions of human Col I (hCol I), hPOSTN and hOPN immunohistochemically on serial sections. Our results demonstrated that BT-PF transplants generated much more hCol I and hPOSTN compared with PF transplants. Furthermore, only BT-PF transplants synthesized hOPN, a non-collagenous protein specifically expressed in cementum tissues. 42 Notably, we got the similar results of in vivo transplantation to those of the previous report 3 by using much less number of cells (1.0Â10 6 vs 4.0Â10 6 ). Taken together, BT-PFs differed significantly in their ability to develop into definite tissues such as a cementum/PDL-like complex when compared with parent PFs.
In conclusion, our findings suggest that the established BT-PF cells in this study represent a novel human multipotent stem cell line generated by ectopic expression of BMP4 and hTERT in primary human PF cells. We demonstrated that BT-PFs exhibited a superior differentiation capacity to develop into osteoblast-like cells, adipocytes and neuron-like cells in vitro, and to stimulate cementum/PDL-like tissue regeneration in vivo. The multipotency of these cells is likely to provide an attractive source of stem cells for therapeutic purposes and regenerative medicine.
MATERIALS AND METHODS
Cell culture
Human PFs were isolated and expanded from normal impacted third molars from three 18-to 25-year-old individuals who visited the dental clinic at National Taiwan University Hospital for extraction, following approved protocols set by the Ethics Committee of National Taiwan University Hospital. The PDL tissue was carefully removed from the surface of the root and then minced gently with a surgical scalpel. The explants were covered with sterilized glass cover slips in a 100-mm culture dish and incubated with Dulbecco's modified Eagle medium (DMEM) (GIBCO BRL, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS), 50 mg ml -1 streptomycin and 50 U ml -1 penicillin (GIBCO BRL) at 37 1C in a humidified atmosphere of 5% CO 2 and 95% air. 43 Cells from passages 3-8 were used in the experiments. HEK 293 cells and Saos-2, a human osteogenic sarcoma cell line, were cultured under the same conditions.
Construction and transfection of BMP4 and hTERT expression vector
The full-length hBMP4 complementary DNA (cDNA) and hTERT cDNA were subcloned into the pEGFP-N2 vector and pIRES2-EGFP Vector (Clontech Laboratories, Palo Alto, CA, USA), respectively, which contained a neomycin resistance gene for the selection of stably transfected clones. These two plasmids are denoted as pBMP4/EGFP and phTERT/EGFP throughout the paper. Transfections with the pBMP4/EGFP and the phTERT/GFP vectors were performed using Lipofectamine 2000 Reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. We have used the following procedure to co-transfect BMP4 and hTERT plasmid into PF cells in a 10-cm culture dish format. Preparation of complexes using a ratio of plasmid (24 mg¼12 mg BMP4+12 mg hTERT) to Lipofectamine 2000 (60 ml) for the cells (90-95% confluent at the time of transfection) was carried out in serum-free DMEM. The complexes that had been added to the dish containing medium and cells were replaced after 24 h with 10 ml medium. These cells were exposed to 10% FBS/DMEM supplemented with 800 mg ml -1 G418 (GIBCO BRL) for 14 days and then kept in a lower concentration of G418 (200 mg ml -1 ) for maintenance. The surviving cells are referred to as BT-PFs in this study.
Gene detection by semiquantitative RT-PCR
For RT-PCR, total RNA was extracted from cells using Tri Reagent (Sigma, St Louis, MO, USA). Purified RNA (2 mg) was then reverse transcribed with an oligo-dT primer using AMV first-strand cDNA synthesis kit (Invitrogen) for the first-strand cDNA synthesis. PCR was performed using PCR Master Mix (Promega Co., Madison, WI, USA) and specific primers for endogenous BMP4, ectopically encoded exogenous BMP4, endogenous hTERT and ectopically encoded exogenous hTERT. To distinguish BMP4 and hTERT expressions, each set of primers was specific for endogenous BMP4 and hTERT or exogenous BMP4 and hTERT, but not for both. 44 Human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers were used as internal standards. Additional primer sequences and PCR conditions are listed in Table 1 . PCR products were separated using 2% agarose gel electrophoresis.
Assay for BMP4 activity
To determine the in vitro BMP4 activity, the media supernatants from cell cultures of the PFs and BT-PFs were harvested. BMP4 in the supernatants was measured using a BMP4 ELISA kit (RayBiotech, Inc., Norcross, GA, USA). Measurements were performed in triplicate. 
Multilineage differentiation assays and histochemical staining
For all differentiation assays, PFs and BT-PFs of passages 6-9 were used and treated with one of the following culture conditions: (1) oDM of DMEM supplemented with 10% FBS, 50 mM L-ascorbic acid 2-phosphate, 10 mM b-glycerophosphate and 100 nM dexamethasone (Sigma); (2) aDM of DMEM supplemented with 10% FBS, 0.5 mM hydrocortisone, 60 mM indomethacin and 0.5 mM 3-isobutyl-1-methylxanthin (Sigma); and (3) nDM of serum-free DMEM supplemented with 125 ng ml -1 basic fibroblast growth factor, 1000 unit ml -1 leukemia inhibitory factor and 4 mM forskolin (Sigma). After treatment with a differentiation medium, cells were analyzed using histochemical staining.
Immunofluorescence analysis
Cells were fixed with 4% formaldehyde for 30 min and permeabilized with 0.2% Triton X-100 before the blocking of nonspecific regions with 1% bovine serum albumin. Primary antibodies were incubated at 4 1C overnight and then washed with phosphate-buffered saline three times. The antibodies included those specific for anti-human nestin monoclonal antibody (1:200), anti-GFAP monoclonal antibody (1:400) and anti-MAP monoclonal antibody (1:250) and were all purchased from Millipore. Secondary antibodies were incubated at 4 1C for 3 h. Immune complex was detected with Alexa Fluor 568-conjugated goat anti-mouse IgG (1:200; Invitrogen), and nuclei were stained with 4,6-diamidino-2-phenylindole for double-label immunocytofluorescence studies.
Analysis of Smad pathways using western blotting
PFs and BT-PFs were incubated in oDM or oDM with rhBMP4 (250 ng ml -1 ) for the indicated time periods. The cells were lysed in lysis buffer (10 mM TrisHCl, pH 7.5, 200 mM NaCl, 1% Triton X-100, 0.1 mM sodium orthovanadate, 50 mM sodium fluoride and 1 mM phenylmethylsulfonyl fluoride). Protein (50 mg) was fractionated via 6 or 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to a polyvinylidene fluoride membrane (Pall Corporation, Port Washington, NY, USA). Primary antibodies used in this study included those against Smad 1/5/8 and phospho-Smad 1/5/8 (1:6000; Cell Signaling Technology, Boston, MA, USA) and actin antibody (1:20 000; R&D Systems, Minneapolis, MN, USA). After incubation with the secondary antibody (horseradish peroxidase-conjugated anti-rabbit IgG, 1:5000; Sigma) for 1 h at room temperature, binding of the secondary antibody was detected using an ECL detection kit (GE Health Science, Waukesha, WI, USA) according to the manufacturer's instructions.
Time-lapse imaging
For time-lapse analysis, PFs and BT-PFs cultured in nDM were maintained in a CO 2 -and temperature-controlled chamber under a Zeiss Axiovert 200M Fluorescence/Live cell Imaging Microscope (Zeiss, Berlin, Germany).
In vivo transplantation assay
A total of 30 CB 17 mice will be randomized into three groups based on the treatment received, the carrier control and PF and BT-PF groups. In the PF and BT-PF groups, the cells (1Â10 6 of PFs and BT-PFs) will be mixed with 40 mg of HA/TCP ceramic particle (Sinbone, Purzer, Taipei City, Taiwan) and then transplanted subcutaneously into the dorsal surfaces of 8-week-old NOD/SCID mice as previously described. 3, 45 In the carrier control group, only the HA/TCP will be transplanted subcutaneously. At 8 weeks after transplantation, the transplants were fixed with 4% paraformaldehyde, decalcified in buffered 10% edetic acid and embedded in paraffin. Sections were prepared and stained with hematoxylin and eosin, Masson's trichrome or immunohistochemical staining. To detect hCol I, hPOSTN and hOPN, human-specific anti-Col I monoclonal antibody (1:500, clone 5D8-G9; Millipore), anti-hPOSTN polyclonal antibody (1:250; BioVendor Laboratory Medicine, Heidelberg, Germany) and anti-hOPN monoclonal antibody (1:250; Novus Biologicals, Littleton, CO, USA) were used, respectively. Isotype-matched antibodies were used for the negative controls. Every sample was treated by further incubation with biotinylated secondary antibody, streptavidin-conjugated horseradish peroxidase complexes (Rockland, Philadelphia, PA, USA) and 3-amino-9-ethyl carbazole solution for further 30 and 10 min, respectively.
Statistical analysis
Data plotted were typically expressed as mean ± s.d. Comparison of differences between two variables was performed using the two-tailed, two-sample with equal variances, Student's t-test. It was judged significant when Po0.05.
